11/14/2025MNCs Face Diverging Fortunes and Strategic Reset in China

11/14/2025NMPA Clears IND for GenSci's In-House Bispecific ADC GenSci140

11/14/2025Adicon to Acquire Crown Bioscience in US$204M Deal

11/14/2025Adagene and Third Arc Bio Sign Licensing Deal for Two Masked CD3 T-Cel...

11/14/2025Recent Executive Moves

11/13/2025Laekna Grants Qilu Pharma Exclusive Greater China Rights to LAE002 (Af...

11/13/2025Kexing Biopharm Files for Hong Kong IPO to Advance Biologic and Target...

11/13/2025InSilico Files for Hong Kong IPO to Accelerate AI-Driven Drug Discover...

11/13/2025Kind Pharma Secures Over CNY 400M in Series C Financing to Advance L...

11/13/2025Groovy Secures Series A Financing to Advance AI-Driven Drug Discovery ...

11/13/2025GenFleet Registers First Phase 3 Trial of KRAS G12D Inhibitor GFH375 i...

11/13/2025Biokin Postpones Planned Hong Kong IPO Amid Market Conditions

11/13/2025Global Pharma and Biotech Leaders Announce New China Investments at CI...

11/13/2025Alcon Expands China Strategy with Focus on Accessibility and Innovatio...

11/13/2025WuXi AppTec Establishes European Headquarters in Munich

11/13/2025Innovative Antibody Therapeutic Development in China Compared with the...

11/12/2025Brightintel Secures Multi-Million CNY Series Pre-A Funding to Advance ...

11/12/2025DeliNova Raises CNY 60M in Seed and Angel Financing to Advance In Vivo...

11/12/2025Aureka Closes Multi-Million-Dollar Series A to Advance Pipeline and AI...

11/12/2025Brise Secures Over CNY 200M Series A to Advance Pain Management Pipeli...

11/12/2025Lyell Acquires Global Rights to ICT's Next-Generation CAR-T Therapy LY...

11/12/2025Rona Thera Unveils Promising Phase 1 Data for Long-Acting APOC3 siRNA ...

11/12/2025BeOne Launches Global Phase 1 Trial of FIC CDK2 Degrader BG-75098

11/12/2025Indian Pharma Firms Secure Key Wins in China's Latest VBP Round

11/11/2025AZ's Evinova and Harbour BioMed Form AI Partnership to Advance Biologi...

11/11/2025MeiraGTx and Eli Lilly Form Strategic Partnership to Advance Gene Ther...

11/11/2025Huahui to Present 48-Week Phase 2b Data of Libevitug at AASLD 2025

11/11/2025Innovent and SanegeneBio Present Positive Phase 1 Data for siRNA Thera...

11/11/2025SanegeneBio and Eli Lilly Form RNAi Collaboration in Metabolic Disease...

11/11/2025Summit and Akeso Report Positive Phase III Results for Ivonescimab at ...

Page:4/803 Total number of articles:24077: [First][<<] [2] [3] [4] [5] [6] [>>] [End]